X4 Pharmaceuticals (XFOR) Misses Q3 EPS by 4c; Cash and Cash Equivalents of $77.7M

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.76), $0.04 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Worried the AI trade has gone too far? Evercore likes these 4 stocks